This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: The Innovations of Robert R. Freeman
Introduction
Robert R. Freeman is a notable inventor based in London, GB. He has made significant contributions to the field of immunology, particularly in the development of antigens related to the Plasmodium genus, which is responsible for malaria. His work has implications for vaccine development and the induction of immunity in vertebrate hosts, including humans.
Latest Patents
Freeman holds a patent for "Protozoal antigen," which describes protection-inducing antigens or parasites of the genus Plasmodium. The antigens have an apparent molecular weight of 1.8 to 2.5 × 10^5 and are associated with the membranes of the erythrocytic schizont forms of the parasite. These antigens can be incorporated into vaccines, providing a method for inducing immunity in susceptible vertebrate hosts.
Career Highlights
Freeman has worked with Burroughs Wellcome Co., where he has been able to apply his research in practical settings. His innovative approach to vaccine development has positioned him as a key figure in the fight against malaria.
Collaborations
One of his notable collaborators is Anthony A. Holder, with whom he has worked on various projects related to his patent.
Conclusion
Robert R. Freeman's contributions to the field of immunology and vaccine development highlight the importance of innovation in addressing global health challenges. His work continues to inspire future research in the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile